Caribou Biosciences annual revenue
2019
2020
2021
2022
2023
2024
2025
Caribou Biosciences Revenue Growth & History (CRBU)
Caribou Biosciences reported $11.2M in revenue for fiscal 2025, an increase of 11.66% from the previous fiscal year.
View full Caribou Biosciences company overviewCaribou Biosciences annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.2M | $1.2M | +11.66% |
| 2024 | 2024-12-31 | $10.0M | −$24.5M | −71.01% |
| 2023 | 2023-12-31 | $34.5M | $20.6M | +148.91% |
| 2022 | 2022-12-31 | $13.9M | $4.3M | +44.31% |
| 2021 | 2021-12-31 | $9.6M | −$2.8M | −22.35% |
| 2020 | 2020-12-31 | $12.4M | $6.6M | +113.56% |
| 2019 | 2019-12-31 | $5.8M | — | — |
Caribou Biosciences quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.5M | −$1.2M | −43.79% |
| Q1 2026 | 2026-03-31 | $2.4M | $44,000 | +1.87% |
| Q4 2025 | 2025-12-31 | $3.9M | $1.9M | +89.74% |
| Q3 2025 | 2025-09-30 | $2.2M | $174,000 | +8.60% |
| Q2 2025 | 2025-06-30 | $2.7M | −$797,000 | −23.01% |
| Q1 2025 | 2025-03-31 | $2.4M | −$76,000 | −3.13% |
| Q4 2024 | 2024-12-31 | $2.1M | −$1.5M | −41.62% |
| Q3 2024 | 2024-09-30 | $2.0M | −$21.6M | −91.45% |
| Q2 2024 | 2024-06-30 | $3.5M | −$291,000 | −7.75% |
| Q1 2024 | 2024-03-31 | $2.4M | −$1.1M | −30.64% |
| Q4 2023 | 2023-12-31 | $3.6M | −$134,000 | −3.63% |
| Q3 2023 | 2023-09-30 | $23.7M | $20.4M | +616.38% |
| Q2 2023 | 2023-06-30 | $3.8M | −$437,000 | −10.42% |
| Q1 2023 | 2023-03-31 | $3.5M | $838,000 | +31.46% |
| Q4 2022 | 2022-12-31 | $3.7M | $1.1M | +44.28% |
| Q3 2022 | 2022-09-30 | $3.3M | −$674,000 | −16.95% |
| Q2 2022 | 2022-06-30 | $4.2M | $2.7M | +184.01% |
| Q1 2022 | 2022-03-31 | $2.7M | $1.1M | +67.97% |
| Q4 2021 | 2021-12-31 | $2.6M | $1.6M | +160.06% |
| Q3 2021 | 2021-09-30 | $4.0M | $2.8M | +231.97% |
| Q2 2021 | 2021-06-30 | $1.5M | −$7.0M | −82.59% |
| Q1 2021 | 2021-03-31 | $1.6M | −$115,000 | −6.76% |
| Q4 2020 | 2020-12-31 | $984,000 | — | — |
| Q3 2020 | 2020-09-30 | $1.2M | — | — |
| Q2 2020 | 2020-06-30 | $8.5M | — | — |
| Q1 2020 | 2020-03-31 | $1.7M | — | — |
Caribou Biosciences revenue growth trends
Over the last five reported fiscal years, revenue declined from $12.4M to $11.2M, a compound annual decline of 2.03%. Caribou Biosciences's latest reported quarter, Q2 2026, generated $1.5M in revenue, a decrease of 43.79% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Caribou Biosciences source filings ↗